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Idiopathic pulmonary fibrosis: Now less idiopathic?Idiopathic pulmonary fibrosis (IPF) is a progressive diffuse
fibrosing lung disease that kills increasing numbers of indi-
viduals each year with levels of mortality that exceed those
of many cancers.1 It is an important lung problem for many
reasons including being the most common of the diffuse
fibrosing lung diseases and its awful prognosis. While it is by
definition of unknown origin, there have been reports of
associations with exogenous exposures, including most
consistently cigarette smoking and occupational exposures
to wood and metal dusts.2e6 Although these associations
fall short of being proof of causation, taken together they
provide compelling evidence that ultimately the causation
of IPF, and probably more likely the geneeenvironment
associations that together trigger IPF, will emerge.
Of the other triggers that have been suggested in the
literature to be possible candidates, gastro-oesophageal
reflux has become increasingly prominent. There are
several studies that report an association between pulmo-
nary fibrosis and gastro-oesophageal reflux. In two of these
a higher incidence of gastro-oesophageal reflux was found
in patients with IPF compared with normal individuals.7e9 In
a third study, gastro-oesophageal reflux-induced oesopha-
gitis was linked with pulmonary fibrosis.9 In a study of
patients with end-stage IPF on a lung transplant waiting
list, two thirds of were found to have gastro-oesophageal
reflux.10 Interestingly, the typical symptoms (heartburn and
regurgitation) could not distinguish between those with and
without gastro-oesophageal reflux. In another study of
patients on a lung transplant waiting list for a variety of
chronic lung diseases, abnormal oesophageal function was
observed in almost 75% of cases independent of the original
disease that had reached end stage.11 The disorder is
clinically silent in many patients.8
A possible association with diabetes mellitus has also
been reported. Two studies have suggested that diabetes
mellitus may be a risk factor for IPF.12,13 In one of these
a roughly three-fold increase in the prevalence of diabetes
mellitus was found in IPF compared with controls.12
With this background, the study by Gribbin et al that
appears in this edition of Respiratory Medicine14 provides
further support for the association of both diabetes mellitus
and gastro-oesophageal reflux with IPF. In a very large study
that used data from a longitudinal primary health care0954-6111/$ - see front matter ª 2009 Elsevier Ltd. All rights reserved
doi:10.1016/j.rmed.2009.03.014database that included diagnosis and prescribing data, the
authors identified 920 individuals with IPF. Associations with
the diagnoses of gastro-oesophageal reflux and diabetes and
also with the drugs used to treat these conditions were
compared with data from 3593 matched controls from the
same database. The authors found greater associations with
both disorders and the drugs used to treat them in the IPF
group compared with controls after appropriate adjustment
for confounding factors. The authors acknowledge the main
weaknesses of the study: the possible inaccuracy of both the
diagnosis of IPF and of the validity of the exposure histories.
There was also the possibility of ascertainment bias whereby
IPF might have been more likely to be diagnosed because
individuals were already being evaluated for diabetes or
gastro-oesophageal reflux. To this needs to be added the
critique that controls need to have an equal opportunity to
be a case: to use controls from primary care practices rather
than secondary or tertiary care centres makes the possibility
of identifying the presence of significant gastro-oesophageal
reflux or diabetes mellitus less likely and this raises a second
possible reason for inadvertent ascertainment bias.
Furthermore, the findings that only associations with drugs
used to treat the conditions not the presence of the condi-
tions themselves, emerged from multivariate analyses are
intriguing with regard to interpretation.
Three issues stand out. First, does precision of diagnosis
matter in the context of this study? Probably not. The purists
would want to identify associations if not causes for specific
diseases rather than amore loose disease groupinge and the
author is generally one of these e but increasingly it is being
recognized that there is diagnostic imprecision evenwhen all
diagnostic indices, including surgical lung biopsy, are avail-
able. In this context, it is unlikely that patients who do not
have diffuse lung fibrosis are being included in this study,
even if they do not all have IPF, so the epidemiology remains
sound. The second question is whether this is cause or effect.
Patients with IPF are often more sedentary and overweight
and thereby prone to have gastro-oesophageal reflux and
diabetes. The fact that the diagnoses antedated that of IPF
does not affect this view, given that IPF is a disease that
generally presents at a late physiological stage and so must
have been present for considerable periods of time before
the presentation for the lung problem. Given that previous.
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oesophageal disease with any accuracy without pH
measurements as it is often a ‘‘silent’’ problem and also
given that reflux has been reported in other chronic lung
diseases as divergent as asthma and bronchiectasis, it is
more likely that this is a co-incident finding. But what if it
were not a co-incidence? How can reflux cause, or at least
contribute to, the development of IPF?
The concept that acid itself reaches the periphery of the
lung unbuffered causing direct, acid-induced epithelial cell
injury is unlikely. Could a more proximal airway insult,
however, have peripheral consequences? This is more
intriguing. In a study of the transient overexpression of
active, but not latent, TGF-b1 to rat lung using an adeno-
viral vector, prolonged and severe interstitial and pleural
fibrosis resulted.15 This occurred despite the fact that the
viral delivery was to proximal airway.
Although the mechanism(s) remain illusive it does show
that a proximal epithelial cell challenge can produce
peripheral IPF-like pathology albeit with the delivery of
a powerful pro-fibrotic mediator. Nonetheless the periph-
eral disease distribution following a more central insult, no
matter how powerfully pro-fibrotic, needs to be explained.
Can gastric contents provoke a similar response via prox-
imal airway epithelial cell triggering? Who knows but this
possibility certainly fits with the emerging concept of
epithelial cells, including possibly peripheral airway rather
than alveolar epithelial cells, orchestrating the fibrotic
response in the interstitium.
Does the paper by Gribbin et al provide any conclusive
answers? The answer is no. What it has done however,
notwithstanding the authors’ own self-critiques to which I
have added mine, is to provide continuing and moderately
convincing evidence of associations and to support the
concept that there are important questions that need to be
answered in prospective studies of disease pathogenesis
and in trials of anti-reflux therapy. And what about the
diabetes link? This is even trickier and defies even the most
speculative hypothesis on a connection with IPF.
So, the authors are to be congratulated on keeping the
debate alive and preventing us from drifting into
a complacent sense of ennui on the role of gastro-oeso-
phageal reflux in IPF. Is IPF less idiopathic? No, not yet but
we are getting closer to the answer.
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